Delve Health Comments on FDA Draft Guidance on Decentralized Clinical Trials for Drugs and Biological Products
Our Review of the New FDA Draft Guidance Decentralized clinical trials (DCTs) have become increasingly popular in recent years due to their potential to increase patient access and reduce the burden of participating in clinical trials. In response to this trend, the US Food & Drug Administration (FDA) has issued new guidance on the use […]
